LONDON – Having become popular with both celebrities and investors, diabetes drugs that also promote weight loss, such as Novo Nordisk’s Ozempic, are now being studied to tackle some of the most difficult-to-treat brain disorders, including Alzheimer’s disease.
Diabetes regimens,…
Source: www.japantimes.co.jp – Read more
Securing Patient Data and Business Continuity: Arizona’s Healthcare CISOs – Security Boulevard
Securing Patient Data and Business Continuity: Arizona’s Healthcare CISOs Security Boulevard
